Physician profile
Bridgette E Williams
NPI 1104130806
$34,805.98
in general payments reported to CMS, 2019-2025
44 companies · $2,111 in 2025
The $2,111 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $8,464 · 2022: $17K · 2023: $3,933 · 2024: $3,349 · 2025: $2,111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,613 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Consulting Fee: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,612.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Consulting Fee | $280.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29,069.72 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $730.84 | 2021-2025 | Lynparza, Calquence, Enhertu |
| Inari Medical, INC. | $492.19 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $380.42 | 2023-2025 | Camzyos, Reblozyl, Opdualag |
| Amgen INC. | $363.74 | 2021-2024 | Repatha, Lumakras |
| Boston Scientific Corporation | $360.16 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, Accolade Sr, Watchman Access System |
| Abbott Laboratories | $337.60 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $324.50 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Daiichi Sankyo INC. | $265.39 | 2023-2025 | Enhertu, Injectafer, Datroway |
| Irhythm Technologies, INC. | $200.68 | 2021-2023 | Zio Xt Patch |
| Pfizer INC. | $194.81 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.90 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $189.86 | 2023-2025 | Libtayo |
| Novartis Pharmaceuticals Corporation | $176.03 | 2023-2025 | |
| Incyte Corporation | $155.02 | 2023-2024 | Pemazyre, Monjuvi, Jakafi |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $134.94 | 2023 | Impella |
| Medtronic, INC. | $130.68 | 2023 | Reveal Linq |
| Foundation Medicine, INC. | $108.85 | 2023 | Foundationone Cdx |
| Eisai INC. | $90.82 | 2023-2025 | |
| Janssen Biotech, INC. | $87.35 | 2023-2025 | Tecvayli, Darzalex, Talvey |
| Pharmacosmos Therapeutics INC. | $81.64 | 2024-2025 | Monoferric, Cosela |
| Genentech USA, INC. | $64.07 | 2023-2024 | Venclexta, Tecentriq, Gazyva |
| Takeda Pharmaceuticals U.S.A., INC. | $55.50 | 2024-2025 | Ninlaro |
| Glaxosmithkline, LLC. | $52.37 | 2024-2025 | Ojjaara, Zejula, Jemperli |
| Beone Medicines USA, INC. | $47.86 | 2025 | Brukinsa, Tevimbra |
| Sobi, INC | $45.69 | 2024-2025 | |
| Kyowa Kirin, INC. | $42.99 | 2025 | |
| Abbvie INC. | $42.73 | 2024-2025 | |
| Lilly USA, LLC | $38.27 | 2022-2023 | Retevmo, Jaypirca, Verzenio |
| Alexion Pharmaceuticals, INC. | $37.94 | 2024 | Ultomiris |
| Tersera Therapeutics LLC | $36.26 | 2024-2025 | Zoladex |
| Exelixis INC. | $31.08 | 2024-2025 | Cabometyx |
| Servier Pharmaceuticals LLC | $28.67 | 2023-2024 | |
| Beigene USA, INC. | $26.23 | 2024 | Brukinsa |
| Aveo Pharmaceuticals, INC. | $25.78 | 2025 | |
| Novo Nordisk INC | $24.39 | 2022 | |
| Taiho Oncology, INC. | $24.03 | 2024 | |
| Fennec Pharmaceuticals, INC. | $23.64 | 2025 | Fyarro |
| Celgene Corporation | $18.83 | 2025 | Reblozyl |
| Geron Corporation | $17.56 | 2025 | Rytelo |
| Mirati Therapeutics, INC. | $15.09 | 2023 | Krazati |
| Puma Biotechnology, INC. | $14.88 | 2023 | |
| Agios Pharmaceuticals, INC. | $13.52 | 2024 | |
| Terumo Medical Corporation | $13.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridgette Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.